ctpM (Q9I0I6, PA2652) review notes

Review session 2026-11-05 (PseudoCAP IBA-seed protocol, tier 2)

Fetched with just fetch-gene PSEAE Q9I0I6 --alias ctpM (accession fetch); accession Q9I0I6 matches the worklist. Reviewed Swiss-Prot entry. No deep-research provider was used; literature found through the UniProt references and the PubMed MCP, and the cited papers were cached with ai-gene-review fetch-pmid. PMC full text could not be retrieved through the PubMed MCP for the PseudoCAP seed papers with PMC ids (empty body), so those were read as abstracts; the confidence rule is not engaged because no defect is recorded.

Identity

Literature

Annotation decisions

PseudoCAP IBA-seed assessment

Node-level assessment: see genes/PSEAE/pctB/pctB-notes.md (recorded once there); summary repeated below.

PTN node node term n_seeds leaf IBAs seed annotation (term, evidence, PMID) verdict rationale other seeds IBD stands without this seed?
PTN001280296 GO:0006935 chemotaxis 10 215 (22 taxa) GO:0006935 and GO:0050918, IMP, PMID:17933940 SOUND Abstract names PA2652 as the malate chemoreceptor from mutant screening; the 2018 paper confirms loss of malate taxis in the mutant and direct malate binding by the LBD. PctA, PctB/PctC, CtpH, CtpL, CtpM, Aer (PseudoCAP IMP); B. subtilis McpC (IDA/IMP positive chemotaxis); B. subtilis and H. salinarum HemAT (IDA aerotaxis) Yes; independent IDA seeds (McpC, two HemATs) and six other PseudoCAP seeds

No source_defects were recorded; no GO_CENTRAL defect for the shared node.